| Page 1718 | Kisaco Research
 

Fiona Davies

National Buyer
Holland and Barrett

Fiona previously worked in the wine industry within Aldi’s award-winning buying team. She moved into category management at Holland & Barrett in October 2018 and spearheaded the alcohol free proposition, sourcing new and innovative suppliers with the intention of offering customers an exciting mix of quality alcohol free options on the high street. The range launched in July 2019 and is growing in success, accounting for 50% of the total ‘free from’ category sales.

Fiona Davies

National Buyer
Holland and Barrett

Fiona Davies

National Buyer
Holland and Barrett

Fiona previously worked in the wine industry within Aldi’s award-winning buying team. She moved into category management at Holland & Barrett in October 2018 and spearheaded the alcohol free proposition, sourcing new and innovative suppliers with the intention of offering customers an exciting mix of quality alcohol free options on the high street. The range launched in July 2019 and is growing in success, accounting for 50% of the total ‘free from’ category sales.

 

Michal Sharon

Associate Professor
The Weizmann Institute

Michal Sharon

Associate Professor
The Weizmann Institute

Michal Sharon

Associate Professor
The Weizmann Institute
 

Matthew Bogyo

Group Leader and Professor
Stanford University School of Medicine

Matthew Bogyo

Group Leader and Professor
Stanford University School of Medicine

Matthew Bogyo

Group Leader and Professor
Stanford University School of Medicine
 

Marcus Groettrup

Chair of Immunology
Konstanz University

Marcus Groettrup

Chair of Immunology
Konstanz University

Marcus Groettrup

Chair of Immunology
Konstanz University
 

Lawrence Dick

Principal
Seofon Consulting

Lawrence Dick

Principal
Seofon Consulting

Lawrence Dick

Principal
Seofon Consulting
 

Kandaswamy Vijayan

CEO
Plexium

Kandaswamy Vijayan

CEO
Plexium

Kandaswamy Vijayan

CEO
Plexium
 

John Price

Assistant Professor
Brigham Young University

John Price

Assistant Professor
Brigham Young University

John Price

Assistant Professor
Brigham Young University
 

John Houston

CEO
Arvinas

John Houston

CEO
Arvinas

John Houston

CEO
Arvinas
 

James Winkler

Head of Degrader Technologies
Frontier Medicines

James Winkler

Head of Degrader Technologies
Frontier Medicines

James Winkler

Head of Degrader Technologies
Frontier Medicines
 

Hyunsun Jo

CEO
Pin Therapeutics

Dr. Hyunsun Jo is an entrepreneur in the biopharmaceutical industry. He is currently a Founder and Chief Executive Officer at Pin Therapeutics, which is located in South San Francisco and South Korea. Pin Therapeutics is backed by many venture capitals in South Korea and actively developing integrative drug discovery platform at the field of protein degradation therapeutics using small molecules. Prior to founding Pin Therapeutics, Dr. Jo has founded two biotech companies called by a LabQnA and an Embedbio.

Hyunsun Jo

CEO
Pin Therapeutics

Hyunsun Jo

CEO
Pin Therapeutics

Dr. Hyunsun Jo is an entrepreneur in the biopharmaceutical industry. He is currently a Founder and Chief Executive Officer at Pin Therapeutics, which is located in South San Francisco and South Korea. Pin Therapeutics is backed by many venture capitals in South Korea and actively developing integrative drug discovery platform at the field of protein degradation therapeutics using small molecules. Prior to founding Pin Therapeutics, Dr. Jo has founded two biotech companies called by a LabQnA and an Embedbio. He obtained his BA and PhD in Molecular Biology (Metabolic Diseases) at Seoul National University and Postdoc (aging-related diseases) at the Gladstone Institute (UCSF).